Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Carbon nanotubes enhance CpG uptake and potentiate antiglioma immunity.

Zhao D, Alizadeh D, Zhang L, Liu W, Farrukh O, Manuel E, Diamond DJ, Badie B.

Clin Cancer Res. 2011 Feb 15;17(4):771-82. doi: 10.1158/1078-0432.CCR-10-2444. Epub 2010 Nov 18.

2.

Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy.

Alizadeh D, Zhang L, Brown CE, Farrukh O, Jensen MC, Badie B.

Clin Cancer Res. 2010 Jul 1;16(13):3399-408. doi: 10.1158/1078-0432.CCR-09-3087. Epub 2010 Jun 22.

3.

Intracerebral CpG immunotherapy with carbon nanotubes abrogates growth of subcutaneous melanomas in mice.

Fan H, Zhang I, Chen X, Zhang L, Wang H, Da Fonseca A, Manuel ER, Diamond DJ, Raubitschek A, Badie B.

Clin Cancer Res. 2012 Oct 15;18(20):5628-38. doi: 10.1158/1078-0432.CCR-12-1911. Epub 2012 Aug 17.

4.

TLR ligands in the local treatment of established intracerebral murine gliomas.

Grauer OM, Molling JW, Bennink E, Toonen LW, Sutmuller RP, Nierkens S, Adema GJ.

J Immunol. 2008 Nov 15;181(10):6720-9.

5.
6.

CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model.

Jordan M, Waxman DJ.

Cancer Lett. 2016 Apr 1;373(1):88-96. doi: 10.1016/j.canlet.2015.11.029. Epub 2015 Dec 3.

7.

Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.

Carpentier AF, Xie J, Mokhtari K, Delattre JY.

Clin Cancer Res. 2000 Jun;6(6):2469-73.

8.

Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.

VanHandel M, Alizadeh D, Zhang L, Kateb B, Bronikowski M, Manohara H, Badie B.

J Neuroimmunol. 2009 Mar 31;208(1-2):3-9. doi: 10.1016/j.jneuroim.2008.12.006. Epub 2009 Jan 31.

PMID:
19181390
9.

Metronomic Doses of Temozolomide Enhance the Efficacy of Carbon Nanotube CpG Immunotherapy in an Invasive Glioma Model.

Ouyang M, White EE, Ren H, Guo Q, Zhang I, Gao H, Yanyan S, Chen X, Weng Y, Da Fonseca A, Shah S, Manuel ER, Zhang L, Vonderfecht SL, Alizadeh D, Berlin JM, Badie B.

PLoS One. 2016 Feb 1;11(2):e0148139. doi: 10.1371/journal.pone.0148139. eCollection 2016.

10.

S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Wang H, Zhang L, Zhang IY, Chen X, Da Fonseca A, Wu S, Ren H, Badie S, Sadeghi S, Ouyang M, Warden CD, Badie B.

Clin Cancer Res. 2013 Jul 15;19(14):3764-75. doi: 10.1158/1078-0432.CCR-12-3725. Epub 2013 May 29.

11.
12.

Treg depletion followed by intracerebral CpG-ODN injection induce brain tumor rejection.

Jarry U, Donnou S, Vincent M, Jeannin P, Pineau L, Fremaux I, Delneste Y, Couez D.

J Neuroimmunol. 2014 Feb 15;267(1-2):35-42. doi: 10.1016/j.jneuroim.2013.12.005. Epub 2013 Dec 12.

PMID:
24369298
13.

Immunotherapeutic approach with oligodeoxynucleotides containing CpG motifs (CpG-ODN) in malignant glioma.

Ursu R, Carpentier AF.

Adv Exp Med Biol. 2012;746:95-108. doi: 10.1007/978-1-4614-3146-6_8. Review.

PMID:
22639162
14.

Implication of macrophages in tumor rejection induced by CpG-oligodeoxynucleotides without antigen.

Auf G, Carpentier AF, Chen L, Le Clanche C, Delattre JY.

Clin Cancer Res. 2001 Nov;7(11):3540-3.

15.

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model.

Ginzkey C, Eicker SO, Marget M, Krause J, Brecht S, Westphal M, Hugo HH, Mehdorn HM, Steinmann J, Hamel W.

Cancer Immunol Immunother. 2010 Apr;59(4):541-51. doi: 10.1007/s00262-009-0771-y. Epub 2009 Oct 2.

PMID:
19798500
16.

Lymphoma B-cell responsiveness to CpG-DNA depends on the tumor microenvironment.

Ben Abdelwahed R, Cosette J, Donnou S, Crozet L, Ouakrim H, Fridman WH, Sautès-Fridman C, Mahjoub A, Fisson S.

J Exp Clin Cancer Res. 2013 Apr 5;32:18. doi: 10.1186/1756-9966-32-18.

17.

Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.

Merlo A, Calcaterra C, Mènard S, Balsari A.

J Leukoc Biol. 2007 Sep;82(3):509-18. Epub 2007 Jun 22.

PMID:
17586660
18.

In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.

Wu A, Oh S, Gharagozlou S, Vedi RN, Ericson K, Low WC, Chen W, Ohlfest JR.

J Immunother. 2007 Nov-Dec;30(8):789-97.

PMID:
18049330
19.
20.

Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.

Sielska M, Przanowski P, Wylot B, Gabrusiewicz K, Maleszewska M, Kijewska M, Zawadzka M, Kucharska J, Vinnakota K, Kettenmann H, Kotulska K, Grajkowska W, Kaminska B.

J Pathol. 2013 Jul;230(3):310-21. doi: 10.1002/path.4192.

PMID:
23520016

Supplemental Content

Support Center